CLRO · ClearOne, Inc.

ClearOne, Inc. (CLRO) underwent a fundamental operational shift in FY2025, completing the sale of certain intellectual property, product inventory, and non-exclusive customer data rights on October 24, 2025 (the 'Asset Sale'). This transaction, as detailed in Item 7 - Management's Discussion and Analysis, ended the Company's manufacturing and product sales activities. Consequently, continuing operations generated $0 revenue for the full year ended December 31, 2025, with the Company now limited to maintaining minimal inventory and providing customer support for warranty claims.

Gross profit from continuing operations stood at -$328K, reflecting costs associated with warranty fulfillment absent any revenue generation. This outcome stems directly from the Asset Sale's aftermath, where prior reduced sales volumes, inventory write-downs, severance, and restructuring costs eroded margins even before disposition. Operating income totaled -$4.4M, capturing the broader wind-down of legacy product operations alongside transitional expenses.

The most significant impact appeared in net income, which reached -$26.1M, or diluted EPS of -$14.77. These figures were driven predominantly by discontinued operations results, encompassing operating losses prior to the Asset Sale closing, inventory write-downs, severance and restructuring costs, and the recognized loss on sale in Q4 2025. Management's discussion highlights how these elements collectively pressured gross margins and operating results throughout the year.

Overall, FY2025 results illustrate a company in strategic transition following the Asset Sale. Investors should monitor progress on these alternatives, as ongoing warranty support alone cannot offset the discontinued operations' legacy burdens or address liquidity needs.